ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 330 filers reported holding ARGENX SE in Q2 2024. The put-call ratio across all filers is 1.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $4,229,341 | +4.2% | 10,742 | +0.7% | 0.01% | 0.0% |
| Q4 2023 | $4,059,567 | -33.4% | 10,671 | -13.9% | 0.01% | -40.0% |
| Q3 2023 | $6,091,296 | +24.6% | 12,390 | -1.2% | 0.01% | +25.0% |
| Q2 2023 | $4,889,163 | +5.9% | 12,545 | +1.2% | 0.01% | 0.0% |
| Q1 2023 | $4,618,128 | -3.8% | 12,395 | -2.2% | 0.01% | -11.1% |
| Q4 2022 | $4,801,670 | +2.4% | 12,675 | -4.5% | 0.01% | 0.0% |
| Q3 2022 | $4,688,000 | -12.3% | 13,277 | -5.9% | 0.01% | -10.0% |
| Q2 2022 | $5,345,000 | +5.8% | 14,106 | -11.9% | 0.01% | +25.0% |
| Q1 2022 | $5,051,000 | +54.3% | 16,017 | +71.3% | 0.01% | +100.0% |
| Q4 2021 | $3,274,000 | +343.0% | 9,349 | +57.8% | 0.00% | +100.0% |
| Q1 2019 | $739,000 | – | 5,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |